InvestorsHub Logo
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

Re: MMMQA post# 38254

Wednesday, 11/18/2015 10:40:28 AM

Wednesday, November 18, 2015 10:40:28 AM

Post# of 459489
Yes, safety and absorption have been established. Presently, the FDA is of the mind to approve this drug for AD if it is shown in this larger trial that it has any degree of efficacy at all. Safety is of utmost importance to the FDA. All of this is extremely encouraging -- especially with what we know about the science. Remember too, that none of the other AD drugs on the market work with the possible exception of Aricept. Do not be concerned about Adam F saying things, including his ridiculous comment about Anavex 2-73 making some patients dizzy. All CNS drugs make some patients dizzy (blood pressure and other drugs do too). Frankly, Aricept makes some patients dizzy - the FDA approved Aricept knowing it made some patients dizzy!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News